Cellular targets of adriamycin-induced damage in Escherichia coli

Biochemical Pharmacology
|October 1, 1986
PubMed

Insights

Adriamycin (ADR) primarily targets DNA in E. coli, inhibiting RNA synthesis and interfering with DNA template function. Bacterial DNA repair mechanisms, including the SOS system, can repair ADR-induced lesions.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Adriamycin (ADR) is a widely used chemotherapeutic agent with known DNA-damaging properties.
  • Understanding the precise cellular targets and mechanisms of ADR in bacteria like Escherichia coli is crucial for comprehending its effects and potential resistance.

Purpose of the Study:

  • To elucidate the primary cellular targets of adriamycin (ADR) activity in Escherichia coli.
  • To investigate the correlation between ADR's effects on cellular functions and bacterial mortality.
  • To determine the role of DNA repair pathways in response to ADR-induced cellular damage.

Main Methods:

  • Assessing colony-forming ability and various cellular functions (RNA, DNA, protein synthesis, membrane function, oxygen consumption) in E. coli exposed to ADR.
  • Investigating the involvement of the stringent response and nalidixic acid-induced DNA synthesis inhibition.
  • Analyzing the activation of the SOS repair system and the role of recA-dependent functions in repairing ADR-induced lesions.

Main Results:

  • Inhibition of RNA synthesis showed the strongest correlation with bacterial mortality.
  • Total DNA synthesis was less affected, potentially indicating concurrent replication inhibition and DNA repair stimulation.
  • ADR activated the bacterial SOS repair system, and recA-dependent functions were capable of repairing the induced DNA lesions.
  • No significant DNA fragmentation was observed.

Conclusions:

  • The primary cellular target of adriamycin (ADR) in E. coli is the DNA, interfering with its template function.
  • RNA synthesis inhibition is a key indicator of ADR-induced cellular toxicity.
  • Escherichia coli possesses functional DNA repair mechanisms, including the SOS response, to counteract ADR-induced DNA damage.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...